tiprankstipranks
Advertisement
Advertisement

JP:190A Stock Latest News

Chordia Therapeutics Doses First Patient in Rogocekib Expansion Cohort
Company AnnouncementsChordia Therapeutics Doses First Patient in Rogocekib Expansion Cohort
13d ago
190A
Chordia Advances Rogocekib Leukemia Trial With FDA-Aligned Expansion Cohorts
PremiumCompany Announcements
Chordia Advances Rogocekib Leukemia Trial With FDA-Aligned Expansion Cohorts
1M ago
190A
Chordia Regains Full Rights to CTX-177 After Ending Ono License Deal
PremiumCompany Announcements
Chordia Regains Full Rights to CTX-177 After Ending Ono License Deal
1M ago
190A
Chordia Therapeutics’ Major Shareholder Diluted Below 10% After Warrant Exercises
PremiumCompany Announcements
Chordia Therapeutics’ Major Shareholder Diluted Below 10% After Warrant Exercises
2M ago
190A
Chordia Therapeutics Narrows Quarterly Loss but Forecasts Continued Full-Year Red Ink
PremiumCompany Announcements
Chordia Therapeutics Narrows Quarterly Loss but Forecasts Continued Full-Year Red Ink
3M ago
190A
Chordia Therapeutics to Record Grant Income in Fiscal Year 2026
PremiumCompany AnnouncementsChordia Therapeutics to Record Grant Income in Fiscal Year 2026
4M ago
190A
Chordia Therapeutics’ CTX-712 Study: A Potential Breakthrough in AML and HR-MDS Treatment
Premium
Company Announcements
Chordia Therapeutics’ CTX-712 Study: A Potential Breakthrough in AML and HR-MDS Treatment
5M ago
190A
Chordia Therapeutics Restructures Capital to Strengthen Financial Foundation
Premium
Company Announcements
Chordia Therapeutics Restructures Capital to Strengthen Financial Foundation
5M ago
190A
Chordia Therapeutics Reports Fiscal Year 2025 Financial Results
PremiumCompany Announcements
Chordia Therapeutics Reports Fiscal Year 2025 Financial Results
6M ago
190A
Chordia Therapeutics Reports Continued Losses in Latest Financial Results
PremiumCompany Announcements
Chordia Therapeutics Reports Continued Losses in Latest Financial Results
9M ago
190A
Chordia Therapeutics Secures Grant for Cancer Therapy Research
PremiumCompany Announcements
Chordia Therapeutics Secures Grant for Cancer Therapy Research
10M ago
190A
Chordia Therapeutics Announces Change in Major Shareholder
PremiumCompany Announcements
Chordia Therapeutics Announces Change in Major Shareholder
11M ago
190A
Chordia Therapeutics Regains Rights to CTX-177 as Ono Discontinues Development
PremiumCompany AnnouncementsChordia Therapeutics Regains Rights to CTX-177 as Ono Discontinues Development
11M ago
190A
Chordia Therapeutics Reports Financial Losses for Six-Month Period Ending February 2025
Premium
Company Announcements
Chordia Therapeutics Reports Financial Losses for Six-Month Period Ending February 2025
12M ago
190A
Chordia Therapeutics Secures Orphan Drug Designation for Rogocekib in the U.S.
Premium
Company Announcements
Chordia Therapeutics Secures Orphan Drug Designation for Rogocekib in the U.S.
1y ago
190A
Chordia Therapeutics Unveils New Research Insights
PremiumCompany Announcements
Chordia Therapeutics Unveils New Research Insights
1y ago
190A
Chordia Therapeutics Focuses on Innovative Drug Development
PremiumCompany Announcements
Chordia Therapeutics Focuses on Innovative Drug Development
1y ago
190A
Chordia Therapeutics Advances Cancer Drug Development
PremiumCompany Announcements
Chordia Therapeutics Advances Cancer Drug Development
1y ago
190A
Chordia Therapeutics Enhances Transparency with Earnings Transcript
PremiumCompany Announcements
Chordia Therapeutics Enhances Transparency with Earnings Transcript
1y ago
190A
Chordia Therapeutics’ Successful CTX-712 Trial Results
PremiumCompany AnnouncementsChordia Therapeutics’ Successful CTX-712 Trial Results
1y ago
190A
Chordia Therapeutics Faces Fiscal Year Losses
Premium
Company Announcements
Chordia Therapeutics Faces Fiscal Year Losses
1y ago
190A
Chordia Therapeutics Unveils Promising Cancer Drug Trial
Premium
Company Announcements
Chordia Therapeutics Unveils Promising Cancer Drug Trial
1y ago
190A

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >